- Home
- LNKB vs TKNO Comparison
LNKB vs TKNO Comparison
Compare LNKB & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNKB
- TKNO
- Stock Information
- Founded
- LNKB 2018
- TKNO 1996
- Country
- LNKB United States
- TKNO United States
- Employees
- LNKB N/A
- TKNO N/A
- Industry
- LNKB
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- LNKB
- TKNO Health Care
- Exchange
- LNKB Nasdaq
- TKNO Nasdaq
- Market Cap
- LNKB 284.4M
- TKNO 390.7M
- IPO Year
- LNKB N/A
- TKNO 2021
- Fundamental
- Price
- LNKB $7.43
- TKNO $7.73
- Analyst Decision
- LNKB Hold
- TKNO Buy
- Analyst Count
- LNKB 1
- TKNO 2
- Target Price
- LNKB $7.50
- TKNO $5.00
- AVG Volume (30 Days)
- LNKB 78.0K
- TKNO 206.5K
- Earning Date
- LNKB 01-27-2025
- TKNO 11-07-2024
- Dividend Yield
- LNKB 3.89%
- TKNO N/A
- EPS Growth
- LNKB 61.51
- TKNO N/A
- EPS
- LNKB 0.17
- TKNO N/A
- Revenue
- LNKB $86,138,000.00
- TKNO $36,347,000.00
- Revenue This Year
- LNKB N/A
- TKNO $3.47
- Revenue Next Year
- LNKB $9.49
- TKNO $12.07
- P/E Ratio
- LNKB $45.98
- TKNO N/A
- Revenue Growth
- LNKB 151.51
- TKNO N/A
- 52 Week Low
- LNKB $5.86
- TKNO $1.16
- 52 Week High
- LNKB $8.29
- TKNO $8.91
- Technical
- Relative Strength Index (RSI)
- LNKB 50.19
- TKNO 51.60
- Support Level
- LNKB $7.40
- TKNO $7.00
- Resistance Level
- LNKB $7.89
- TKNO $8.89
- Average True Range (ATR)
- LNKB 0.21
- TKNO 0.74
- MACD
- LNKB -0.05
- TKNO -0.09
- Stochastic Oscillator
- LNKB 17.24
- TKNO 38.24
About LNKB LINKBANCORP Inc.
Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.